Summary.-The design, and complications seen during the first 2 years, of a randomized trial of postoperative radiotherapy for rectosigmoid cancer Dukes' B and C are presented and discussed. It is concluded that the present complication rate-below 10% in 221 patients-permits continuation of the intake, which is planned to include 550 patients, to demonstrate a possible increase in crude 5-year survival by 15o% (60-75o% in Dukes' B and 25 40o% in Dukes' C), on the basis of a 0-01 significance level and a probability that the experiment will be successful of 0 90.
rate-below 10% in 221 patients-permits continuation of the intake, which is planned to include 550 patients, to demonstrate a possible increase in crude 5-year survival by 15o% (60-75o% in Dukes' B and 25 40o% in Dukes' C), on the basis of a 0-01 significance level and a probability that the experiment will be successful of 0 90. LOCAL RECURRENCE RATES after surgery for rectosigmoid cancer amount to 5000 at necropsy (Gunderson, 1976) . This high figure seems to be lowered by postoperative radiotherapy (Turner et al., 1977; Withers & Romsdahl, 1977) and the 5-year survival rate may possibly be higher in patients with rectosigmoid cancers Dukes' B (Mendiondo et al., 1976) as well as Dukes' C (Cohen et al., 1977; Turner et al., 1977) . However, the results of prospective, randomized trials are not yet available (Priestman, 1977; CGreen, 1981) .
Lethal complications after a dose of [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] Gray are probably uncommon, but peritoneal adhesions, intestinal stenoses and perforations demanding repeated surgery may occur in 5-10% of patients (Russell & Welch, 1979; Ghossein et al., 1981) . Postoperative radiotherapy may be preferred because of well-defined localization of tumour during surgery, smaller amounts of tumour tissue than before surgery and avoidance of radiotherapy in patients with Dukes' A tumours and patients with distant metastases, diagnosed during surgery. On the other hand, postoperative radiotherapy may be postponed because of surgical complications, tumour spread may occur preoperatively and the blood supply of tumour tissue left behind may be reduced.
The present study was designed to demonstrate a possible gain of 15% in 5-year survivors after postoperative radiotherapy in patients with rectosigmoid cancer Dukes' B and C, with the proviso that the trial cease if severe complications after radiotherapy were seen in more than 10% of the patients. The design and complications observed during the first 2 years of the trial are reported herein, and the question as to whether the preliminary results justify continuation of the study is discussed.
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PATIENTS AND METHODS
Patients with rectosigmoid cancers Dukes' B and C, located in the small pelvis, as evaluated during surgery and operated upon electively and radically in 5 surgical departments, were included in a prospective randomized study which began in September 1979 (Table I ). All other patients with rectosigmoid cancer referred to the 5 departments were included in the prospective study, but without randomization.
The radiotherapy was given in 3 regional departments of oncology, using the same technique.
Before surgery. 9. Bed-ridden less than 50% of day 20-25 days after surgery.
Informed consent was obtained after randomization in patients being allocated to postoperative radiotherapy and the treatment was usually started within 30 days of surgery, but could be postponed for 60 days after surgery. Patients with Dukes' B tumours were allocated at random to postoperative radiotherapy and were stratified according to type of surgery (rectosigmoid resection or abdominoperineal excision) and age (less than 50 years and 50 years or more). The same principle was followed in patients with Dukes' C tumours, as a group per se. Plasma CEA was measured 4 and 10 days after surgery.
Radiotherapy.-The patients were treated in a prone position to give better access to the perineal region and to reduce the dose to the bladder and small intestine and the colostomy. The target volume includes the pelvic cavity with the internal, external and common iliac lymph nodes and extends to the middle of the fifth lumbar vertebra. After abdominoperineal excision the perineal region was included. The urinary bladder was partly excluded from the target volume.
A 3-field technique was used, 1 field from behind and 2 parallel, opposing fields, 1 from each side. The dose in the target volume was equalized by wedges. A total target dose of 50 Gy was given in daily fractions of 2 Gy, 5 days a week. The treatment was given as a split-course during 7 weeks, with a free interval of 2 weeks after 30 Gy. An 8-16 mega-V linear accelerator was used.
A special form was used to register the course of radiotherapy, including possible deviations and side effects. Follow-up :-All patients with rectosigmoid cancer were seen in the 5 surgical departments 6, 12, 24, 36, 48 and 60 months after surgery. A clinical examination including possible rectovaginal exploration and measurement of plasma CEA was always performed and a special form including signs of complications and recurrences was also completed. Proctoscopy was done at each follow-up when an abdominoperineal excision had not been performed, and a barium enema or colonoscopy was done 12, 36 and 60 months after surgery.
Patients with recurrent cancer in the perineal region were treated with radiotherapy, if this had not already been effectuated by randomization. Patients with recurrence in the vicinity of anastomoses were subjected to laparotomy and an attempt to remove the recurrence; if this was impossible, radiotherapy was given, provided that the patient had no previous radiotherapy, and afterwards the patient was re-evaluated as a possible candidate for surgery.
Carcinoembryonic anttigen. -Duplicate samples were taken as EDTA plasma, and the analysis was carried out by the dialysis assay of Hoffinan-La Roche.
The results of CEA measurements in individual patients will not be known to the surgeons and oncologists before the patients have been followed for 5 years; this allows for evaluation of the prognostic value of CEA measurements.
Stati8tic8 and evaluation.-The trial investigates whether adjuvant radiotherapy will increase the chance of 5-year crude survival by at least 15% in patients with rectosigmoid cancer Dukes' B (from approximately 60 to 75%) and Dukes' C (from 25 to 40%). The significance level decided upon (ac) is 0 01 and the desired probability (P) that the experiment will be successful 0 90. To satisfy these conditions, inclusion of 248 patients with Dukes' B tumours and 253 with Dukes' C tumours is necessary (Sokal & Rohlf, 1969) .
In all, 550 patients (275 Dukes' B and 275 Dukes' C) will ultimately be included in the randomized trial, but all patients with rectosigmoid cancer will be registered and followed in the same way.
Differences in morbidities and recurrences will be evaluated by the x2 test, while differences in survival will be evaluated by the log-rank test.
RESULTS
The total number of patients included during the first 26 months are listed in Table I . Reasons for excluding patients with Dukes' B and C tumours from randomization are given in Table II . Randomized treatments are presented in Table III . The number of patients differs from that in Table I , since a small number of patients (7 Dukes' B and 5 Dukes' C) have not yet finished radiotherapy. In spite of allocation to radiotherapy, 5 patients did not have this treatment, because of refusal (2), anastomotic leakage (1), perineal abscess (1) and deterioration (1). Reasons for not completing radiotherapy are given in Table   IV .
Severe complications registered during would not benefit from radiation within the small pelvis, which is the only area the first 26 months in randomized patients considered in the present study. are presented in Table V, excluding those The reasons for exclusion are not very appearing during radiotherapy (Table IV) . restricted and the number of patients
The preliminary status of local recur-available for randomization could be rences and survival for patients with further diminished by excluding patients Dukes' B and C tumours observed for at with asthenic stature, cardiovascular least 6 and at most 24 months is seen in disease, diabetes mellitus and previous Table VI. pelvic surgery, all of whom may have an Pre-and early postoperative CEA increased risk of radiation injury of the values were obtained in most of the small intestine (Swan et al., 1976 ; Loiudice patients and correlated positively with et al., 1977) . The reasons for exclusion used Dukes' classification.
in the present study have resulted in a higher lethality in patients with Dukes' B DISCUSSION and C tumours in whom randomization was not performed (Table VI) Table III clearly demonDukes' C) make the criteria of randomi-strate that the present postoperative radiotherapy programme is not feasible in all patients. Only 85% of those who began the therapy had a complete course of radiation; most reasons for breaking the radiotherapy were directly related to expected side effects (ileus, diarrhoea, perineal dermatitis). A similar proportion of patients completing radiotherapy was seen in a previous randomized study of preoperative radiotherapy (Roswit et al., 1973) .
Severe complications developing after radiotherapy were not significantly more frequent than in patients receiving no radiotherapy (Table V) and only 3 of the 98 (57 + 41) patients allocated to radiotherapy had complications which were undoubtedly due to radiotherapy (intestinal stenosis and perforation). This low figure is similar to those in two recent 10-year reviews of major intestinal complications following radiotherapy to the abdomen, pelvis and perineum (Cram et al., 1977; Deitel & Vasic, 1979) . The present figure may rise during the following years and should possibly be considered higher than stated, including those complications which caused the cessation of radiotherapy before the full dose was given (Table IV) . However, nearly all of these complications were reversible and none was lethal. Rectal bleeding and persisting bladder symptoms were not registered.
No prospective comparisons of complications in patients treated with and without postoperative radiotherapy are available, but it has been stated that complications after preoperative radiotherapy are not more frequent than in surgical series (Stevens et al., 1976) .
The present series is expected to serve as an estimate of possible increased risks of complications after postoperative radiotherapy. So far, the steering committee of the trial considers it justifiable to continue the intake of patients, since the frequency of complications is not greater than that agreed upon.
The frequencies of local recurrence may possibly be lower after radiotherapy, at least in patients with Dukes' C tumours (Table VI) , and a gain in 5-year survivors can be anticipated, but it will take several years before these suggestions can be finally evaluated.
